Key facts
- It has raised $21.6M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Aug 2016.
- Notable investors include US National Science Foundation, MedTech Innovator, United States Department of War, VentureWell, Labcorp Venture Fund — 23 tracked in total.
- Prenosis has filed 1 Form D with the SEC, most recently Sep 2016 ($1.5M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Prenosis
Funding rounds
1 roundsAbout Prenosis
Developer of a health technology innovator intended to usher in a new era of precision diagnostics in acute care using artificial intelligence. The company platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically, enabling doctors and physicians to have real-time information to improve outcomes and reduce hospital costs for patients.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2014
- Employees
- 49
- Website
- prenosis.com/
- Ownership
- Privately Held (backing)
Prenosis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prenosis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prenosis in its N-PORT filings yet. We sweep new filings monthly.